Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Off-label-brug af psykofarmaka til børn og unge i Danmark

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The risks of selective serotonin reuptake inhibitor intake in pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hjernerystelse skal tages alvorligt

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Assessment and treatment of cognitive impairments in patients with affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Chimeric antigen receptor-T-cellebehandling

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Despite regulatory initiatives, psychopharmacological treatment of adolescents is challenged by missing trial data on efficacy and safety. In Denmark, an estimated mean off-label prescription rate of 30-40% in clinical child- and adolescent mental health services has been found in recent studies. The lowest rates were found for drugs treating ADHD (2-3%), and the highest for antipsychotics (96%) and melatonin (100%). The use of melatonin is growing, while the use of other psychopharmacological drugs appears to be stabilizing or decreasing, in spite of an increased number of adolescents treated in Danish mental health services.

Translated title of the contributionOff-label prescription of psychopharmacological drugs for children and adolescents
Original languageDanish
JournalUgeskrift for Laeger
Volume179
Issue number35
Pages (from-to)V05170355
Number of pages5
ISSN0041-5782
Publication statusPublished - 28 Aug 2017

    Research areas

  • English Abstract, Journal Article

ID: 51612374